Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China · Delayed Price · Currency is CNY 35.00
+0.55 (1.60%)
At close: Nov 13, 2026
SHA:603014 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,819 | 1,584 | 818.09 | 649.62 | 595.98 | 339.51 |
Trading Asset Securities | 1,892 | 1,221 | 330.13 | 70.11 | - | 2.29 |
Cash & Short-Term Investments | 3,711 | 2,805 | 1,148 | 719.73 | 595.98 | 341.8 |
Cash Growth | 41.87% | 144.29% | 59.54% | 20.77% | 74.37% | - |
Accounts Receivable | 1,511 | 925.58 | 934.83 | 929.83 | 1,098 | 919.83 |
Other Receivables | 12.93 | 14.41 | 17.26 | 7.23 | 3.37 | 70.36 |
Receivables | 1,524 | 939.99 | 952.1 | 937.07 | 1,101 | 990.19 |
Inventory | 1,413 | 823.25 | 757.07 | 900.14 | 661.07 | 561.22 |
Other Current Assets | 138.09 | 105.48 | 119.19 | 95.66 | 81.56 | 89.53 |
Total Current Assets | 6,786 | 4,674 | 2,977 | 2,653 | 2,440 | 1,983 |
Property, Plant & Equipment | 5,130 | 3,298 | 3,384 | 3,330 | 3,354 | 3,219 |
Long-Term Investments | 297.39 | 177.99 | 142.86 | 170.8 | 126.74 | 104.55 |
Other Intangible Assets | 322.18 | 290.07 | 295.66 | 302.79 | 297.79 | 305.92 |
Long-Term Accounts Receivable | - | - | 0.15 | 0.29 | 0.46 | - |
Long-Term Deferred Tax Assets | 74.07 | 66.44 | 62.55 | 62.88 | 68.9 | 54.59 |
Long-Term Deferred Charges | 31.56 | 8.47 | 7.76 | 11.48 | 15.99 | 21.36 |
Other Long-Term Assets | 166.87 | 93.79 | 120.16 | 151.16 | 105.98 | 251.97 |
Total Assets | 12,808 | 8,608 | 6,990 | 6,682 | 6,410 | 5,940 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 728.94 | 570.4 | 418.9 | 649 | 710.74 | 526.01 |
Accrued Expenses | 186.27 | 204.72 | 193.66 | 207.68 | 226.15 | 138.4 |
Short-Term Debt | 47.38 | - | 3.18 | 6.64 | 41.84 | 679.18 |
Current Portion of Long-Term Debt | 12.63 | - | - | - | - | 121.18 |
Current Portion of Leases | - | 2.9 | 5.48 | 2.87 | 1.92 | 0.32 |
Current Income Taxes Payable | 80.3 | 9.13 | 36.19 | 18.03 | 10.08 | 19.6 |
Current Unearned Revenue | 264.01 | 294.72 | 295.38 | 249.52 | 293.07 | 186.8 |
Other Current Liabilities | 402.88 | 333.52 | 358.97 | 320.72 | 358.92 | 482.47 |
Total Current Liabilities | 1,722 | 1,415 | 1,312 | 1,454 | 1,643 | 2,154 |
Long-Term Leases | 121.24 | 0.03 | 2.65 | 1.04 | 1.83 | - |
Long-Term Unearned Revenue | 78.57 | 71.55 | 78.97 | 89.99 | 98.35 | 109.88 |
Long-Term Deferred Tax Liabilities | 9.53 | 2.81 | - | - | - | - |
Total Liabilities | 1,932 | 1,490 | 1,393 | 1,545 | 1,743 | 2,264 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 694.8 | 417.75 | 370.25 | 370.25 | 370.25 | 350 |
Additional Paid-In Capital | 4,805 | 4,758 | 3,700 | 3,689 | 3,662 | 3,007 |
Retained Earnings | 5,377 | 1,943 | 1,526 | 1,077 | 634.89 | 319.93 |
Comprehensive Income & Other | -0.12 | -0.31 | -0.17 | -0.31 | -0.17 | -0.36 |
Total Common Equity | 10,876 | 7,119 | 5,597 | 5,136 | 4,667 | 3,676 |
Minority Interest | -0.23 | 0.01 | - | - | - | - |
Shareholders' Equity | 10,876 | 7,119 | 5,597 | 5,136 | 4,667 | 3,676 |
Total Liabilities & Equity | 12,808 | 8,608 | 6,990 | 6,682 | 6,410 | 5,940 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 181.24 | 2.93 | 11.3 | 10.55 | 45.6 | 800.68 |
Net Cash (Debt) | 3,530 | 2,802 | 1,137 | 709.18 | 550.38 | -458.88 |
Net Cash Growth | 35.21% | 146.47% | 60.32% | 28.85% | - | - |
Net Cash Per Share | 5.72 | 7.09 | 3.06 | 1.92 | 1.51 | -1.31 |
Filing Date Shares Outstanding | 1,254 | 417.75 | 370.25 | 370.25 | 363.84 | 351.11 |
Total Common Shares Outstanding | 1,254 | 417.75 | 370.25 | 370.25 | 363.84 | 351.11 |
Working Capital | 5,064 | 3,258 | 1,665 | 1,198 | 797.07 | -171.23 |
Book Value Per Share | 8.67 | 17.04 | 15.12 | 13.87 | 12.83 | 10.47 |
Tangible Book Value | 10,554 | 6,829 | 5,301 | 4,834 | 4,369 | 3,371 |
Tangible Book Value Per Share | 8.41 | 16.35 | 14.32 | 13.05 | 12.01 | 9.60 |
Buildings | - | 2,342 | 2,175 | 2,106 | 2,080 | 1,528 |
Machinery | - | 2,229 | 1,883 | 1,795 | 1,769 | 1,714 |
Construction In Progress | - | 322.46 | 768.12 | 667.77 | 549.49 | 824.27 |